RUNX1 is a promising prognostic biomarker and related to immune infiltrates of cancer-associated fibroblasts in human cancers

被引:0
作者
Zhouting Tuo
Ying Zhang
Xin Wang
Shuxin Dai
Kun Liu
Dian Xia
Jinyou Wang
Liangkuan Bi
机构
[1] The Second Affiliated Hospital of Anhui Medical University,Department of Urology
来源
BMC Cancer | / 22卷
关键词
RUNX1; Prognostic biomarker; TCGA; Cancer-associated fibroblasts;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 210 条
[1]  
Siegel RL(2021)Cancer Statistics, 2021 CA Cancer J Clin 71 7-33
[2]  
Miller KD(2018)SnapShot: TCGA-Analyzed Tumors  Cell 173 530-110
[3]  
Fuchs HE(2016)The Gene Expression Omnibus Database Methods Mol Biol 1418 93-95
[4]  
Jemal A(2015)The RUNX family: developmental regulators in cancer Nat Rev Cancer 15 81-382
[5]  
Blum A(2000)CBF–a biophysical perspective Semin Cell Dev Biol 11 377-138
[6]  
Wang P(2020)RUNX1 Dosage in Development and Cancer Mol Cells 43 126-1311
[7]  
Zenklusen JC(2020)Upregulation of RUNX1 Suppresses Proliferation and Migration through Repressing VEGFA Expression in Hepatocellular Carcinoma Pathol Oncol Res 26 1301-4139
[8]  
Clough E(2018)RUNX1 positively regulates the ErbB2/HER2 signaling pathway through modulating SOS1 expression in gastric cancer cells Sci Rep 8 6423-2276
[9]  
Barrett T(2020)Inhibition of RUNX1 promotes cisplatin-induced apoptosis in ovarian cancer cells Biochem Pharmacol 180 114116-2168
[10]  
Ito Y(2012)Defining a tissue stem cell-driven Runx1/Stat3 signalling axis in epithelial cancer Embo J 31 4124-2247